Eventide | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

320 results for “Eventide”

Trials

View all 276 →

Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo

695 participants · First posted Sep 1, 2014

Exenatide for Stress Hyperglycemia

110 participants · First posted Oct 25, 2013

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus

13 participants · First posted Nov 16, 2005

Drugs

View all 21 →

Exenatide(Bydureon, Byetta)

Conditions: Type 2 Diabetes Mellitus

Rx

Evenamide Hydrochloride

4P Exenatide

News

View all 23 →

AdvanCell Raises $315M Series D to Advance Targeted Alpha Radiopharmaceuticals for Cancer

Inventiva Secures €348 Million to Advance Lanifibranor Phase III Trial for MASH

Belite Bio Raises $275 Million in Upsized Private Placement to Advance Retinal Disease Therapies

Page 1 of 32